‌2025 Virtual Annual

Shareholders' Meeting



Wacker Chemie AG





‌We are WACKER -a strong team

insert image





















‌Our values -our compass








‌2024: Good results amid a weak market environment

Sales

EBITDA

EBITDA margin

Net income for the year

5.7

763

13.3

261

billion

million

percent

million

2024

2024

2024

2024







‌We are systematically pursuing our proven dividend policy

Proposed dividend

2024

2.50

per share













Polymers

Silicones

2024: performance of

business divisions

Good performance: Sales at prior-year level, total earnings even above prior year

Biosolutions



Polysilicon

Mixed fortunes:

Performed well:

Sales and earnings higher than previous year

Strong performance with semiconductor-grade polysilicon,

decline for solar-grade polysilicon







‌We are a real global player



Europe (39%) Asia (37%)

Sales in 2024

€ 5.7 billion

Rest of world (5%) The Americas (19%)







‌We are well-positioned financially

Liquidity

Equity ratio

Net cash flow

Net financial debt

1.3

51.4

-326

691

billion

percent

million

million

December 31, 2024

2024

2024

2024





















Silicones

Karlovy Vary, Czech Republic

Silicones

Zhangjiagang, China

‌We invest in profitable growth

Etching line polysilicon

Burghausen, Germany

Biotechnology Center

Munich, Germany

around the world

VAE dispersions

Calvert City, USA

mRNA competence center

Halle/ Saale, Germany









‌Q1 2025: Good start to the year amid persistently weak market environment

Sales

Q1 2025

1.5

billion

EBITDA

Q1 2025

127

million







‌2025: Annual forecast remains unchanged

Sales

2025

EBITDA

2025

6.1 - € 6.4

billion

700 - € 900

million







‌2030: We remain committed to our long-term targets

Sales

EBITDA margin

Capital employed

2030

10

2030

>20

2030

earn 2x

billion

percent

cost of capital





















‌On track with sustainability

Absolute emissions

Current status

2030

-50%

-30%

By 2045

net zero















‌No artificial intelligence without our hyperpure polysilicon















‌True all-rounders: our hightech-silicones















‌Our dispersions make modern, sustainable construction possible















‌Building blocks of

tomorrow's medicine: our biotech solutions





‌Additional strategic priorities:

advance specialties strategy


‌Additional strategic priorities: further increase efficiency and speed



‌Additional strategic priorities: further strengthen the WACKER team's abilities and skills



‌2025 Virtual Annual

Shareholders' Meeting



Wacker Chemie AG





Attachments

  • Original document
  • Permalink

Disclaimer

Wacker Chemie AG published this content on May 07, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 07, 2025 at 12:27 UTC.